Qube Research & Technologies Ltd
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 1729829
LONDON, X0
Position in VNDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,462,777
+$4,280,592 QoQ
Shares Held
729,212
+3430.3% QoQ
Ownership
1.21%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 172 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. VNDA ranks #79 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in VNDA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,462,777 | 729,212 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $182,185 | 20,656 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $894,467 | 179,252 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $98,051 | 21,362 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $131,633 | 27,481 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $1,521,711 | 370,246 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,726,878 | 409,213 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,104,732 | 255,725 | Shares | Sole | 2023-11-13 | |
| 2022-12-31 | $421,540 | 57,042 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $630,477 | 57,842 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $996,139 | 88,076 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,267,422 | 80,779 | Shares | Sole | 2022-02-10 | |
| 2021-06-30 ALXN | — | 117,649 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 ALXN | — | 61,482 | Shares | Sole | 2021-05-14 | |
| 2021-03-31 | $975,999 | 64,980 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 ALXN | — | 37,164 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $214,497 | 16,324 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $151,217 | 15,654 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 ALXN | — | 78,957 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 ALXN | — | 18,868 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||